Two decades after Shinya Yamanaka’s groundbreaking discovery of induced pluripotent stem cells, the scientific community reflects on remarkable progress. His Nobel Prize-winning research identified four key transcription factors that can reprogram adult cells back to embryonic-like states, revolutionizing regenerative medicine.
The Yamanaka factors – Oct4, Sox2, Klf4, and c-Myc – have opened doors to personalized treatments for previously incurable diseases. Scientists worldwide now use iPSCs to model patient-specific conditions, test drug responses, and develop tailored therapies for neurological disorders, heart disease, and diabetes.
Today’s researchers continue building on this foundation, exploring safer reprogramming methods and clinical applications. The anniversary serves as both celebration and motivation for the next generation of stem cell innovations that could transform healthcare forever.
Source: Read original article
